Spots Global Cancer Trial Database for unresectable primary central chondrosarcoma
Every month we try and update this database with for unresectable primary central chondrosarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma | NCT04458922 | Central Chondro... Central Chondro... Dedifferentiate... Metastatic Clea... Metastatic Prim... Unresectable Pr... | Atezolizumab Biopsy Biospecimen Col... Computed Tomogr... | 2 Years - | National Cancer Institute (NCI) | |
Testing the Combination of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma | NCT04340843 | Locally Advance... Metastatic Prim... Unresectable Pr... | Belinostat Biopsy Biospecimen Col... Computed Tomogr... Decitabine and ... Guadecitabine Magnetic Resona... | 18 Years - | National Cancer Institute (NCI) | |
Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma | NCT04458922 | Central Chondro... Central Chondro... Dedifferentiate... Metastatic Clea... Metastatic Prim... Unresectable Pr... | Atezolizumab Biopsy Biospecimen Col... Computed Tomogr... | 2 Years - | National Cancer Institute (NCI) | |
Testing the Combination of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma | NCT04340843 | Locally Advance... Metastatic Prim... Unresectable Pr... | Belinostat Biopsy Biospecimen Col... Computed Tomogr... Decitabine and ... Guadecitabine Magnetic Resona... | 18 Years - | National Cancer Institute (NCI) |